During the past decade, Teton Cancer Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Teton Cancer Institute" are "Head and Neck Neoplasms" (2 trials), "Melanoma" (2 trials), "Multiple Myeloma" (2 trials), "Sarcoma" (2 trials) and "Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Teton Cancer Institute" in a lesser frequency.

Most popular intervention types in "Teton Cancer Institute" are "Other" (2 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biomarker Testing (L)" (1 trials), "Patient Reported Outcomes (P)" (1 trials), "Provider determined" (1 trials) and "Systemic Treatment (T)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Teton Cancer Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Teton Cancer Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Teton Cancer Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Teton Cancer Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".